These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8305971)

  • 1. Mitoxantrone for malignant pleural effusion due to metastatic sarcoma.
    Kelly J; Holmes EC; Rosen G
    Surg Oncol; 1993 Oct; 2(5):299-301. PubMed ID: 8305971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intrapleural mitoxantrone and mepacrine on malignant pleural effusion--a randomised study.
    Bjermer L; Gruber A; Sue-Chu M; Sandström T; Eksborg S; Henriksson R
    Eur J Cancer; 1995 Dec; 31A(13-14):2203-8. PubMed ID: 8652243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local therapy of malignant pleural effusion with mitoxantrone.
    Torsten U; Opri F; Weitzel H
    Anticancer Drugs; 1992 Feb; 3(1):17-8. PubMed ID: 1623210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrapleurally instilled mitoxantrone in metastatic pleural effusions: a phase II study.
    Aasebø U; Norum J; Sager G; Slørdal L
    J Chemother; 1997 Apr; 9(2):106-11. PubMed ID: 9176748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pleurodesis in malignant pleural effusion: bleomycin vs. mitoxantrone].
    Schmidt M; Schaarschmidt G; Chemaissani A
    Pneumologie; 1997 Apr; 51(4):367-72. PubMed ID: 9221383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrapleural cisplatin and cytarabine in the management of malignant pleural effusions: a Lung Cancer Study Group trial.
    Rusch VW; Figlin R; Godwin D; Piantadosi S
    J Clin Oncol; 1991 Feb; 9(2):313-9. PubMed ID: 1988578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of intrapleural OK-432 and cisplatin for malignant pleural effusion in lung cancer patients].
    Shimizu T; Takahashi N; Terakado M; Sato M; Sugane T; Kisohara A; Akusawa H; Tsujino I; Horie T
    Gan To Kagaku Ryoho; 2005 Aug; 32(8):1139-43. PubMed ID: 16121916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of lymphocytes in malignant pleural effusion on the therapeutic efficacy of intrapleural OK-432 in lung cancer patients.
    Shimizu T; Takahashi N; Terakado M; Akusawa H; Tsujino I; Horie T
    Intern Med; 2006; 45(11):715-20. PubMed ID: 16819251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Case of Massive Pleural Effusion: Pleurodesis by Bleomycin.
    Hasan R; Khan OS; Aftabuddin M; Razzaque AM; Chowdhury GA
    Mymensingh Med J; 2016 Apr; 25(2):374-8. PubMed ID: 27277376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleomycin and mitoxantrone in the treatment of malignant pleural effusions. A comparative study.
    Maiche AG; Virkkunen P; Kontkanen T; Möykkynen K; Porkka K
    Am J Clin Oncol; 1993 Feb; 16(1):50-3. PubMed ID: 7678715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intrathoracic infusion with a combination of low-dose minocycline, OK-432 and cisplatin for malignant pleural effusion].
    Ishimori S; Okada S; Yamagata S; Satoh S
    Gan To Kagaku Ryoho; 2005 Mar; 32(3):345-9. PubMed ID: 15791817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitoxantrone pleurodesis to palliate malignant pleural effusion secondary to ovarian cancer.
    Barbetakis N; Vassiliadis M; Kaplanis K; Valeri R; Tsilikas C
    BMC Palliat Care; 2004 Sep; 3(1):4. PubMed ID: 15357871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrapleural hypotonic cisplatin treatment for malignant pleural effusion in 80 patients with non-small-cell lung cancer: a multi-institutional phase II trial.
    Seto T; Ushijima S; Yamamoto H; Ito K; Araki J; Inoue Y; Semba H; Ichinose Y;
    Br J Cancer; 2006 Sep; 95(6):717-21. PubMed ID: 16940982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of chemical pleurodesis with mitoxantrone in malignant pleural effusion from breast cancer.
    Barbetakis N; Antoniadis T; Tsilikas C
    World J Surg Oncol; 2004 May; 2():16. PubMed ID: 15153245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions.
    Perng RP; Chen YM; Wu MF; Chou KC; Lin WC; Liu JM; Whang-Peng J
    Respir Med; 1998 Mar; 92(3):473-9. PubMed ID: 9692108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapleural chemotherapy without pleurodesis for malignant pleural effusions. LCSG Trial 861.
    Figlin R; Mendoza E; Piantadosi S; Rusch V
    Chest; 1994 Dec; 106(6 Suppl):363S-366S. PubMed ID: 7988265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intrapleural mitoxantrone for the palliative treatment of malignant pleural effusions.
    Morales M; Expósito MC
    Support Care Cancer; 1995 Mar; 3(2):147-9. PubMed ID: 7539702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Local treatment of malignant pleural effusion in gynecologic tumors].
    Seitzer D; Musch E; Kuhn W
    Zentralbl Gynakol; 1990; 112(12):757-65. PubMed ID: 2220170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrapleural streptokinase in multiloculated malignant pleural effusion.
    Dixit R; Dixit K; Bansal R
    Indian J Chest Dis Allied Sci; 2004; 46(1):59-62. PubMed ID: 14870872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EGFR mutations predict a favorable outcome for malignant pleural effusion of lung adenocarcinoma with Tarceva therapy.
    Guo H; Wan Y; Tian G; Liu Q; Kang Y; Li Y; Yao Z; Lin D
    Oncol Rep; 2012 Mar; 27(3):880-90. PubMed ID: 22134479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.